Clinical trial
A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions
NCT00495898 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00495898 |
|---|---|
| Title | A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions |
| Official title | A German Multicenter, Randomized, Controlled, Open-Label Study of the Cypher Sirolimus-Eluting Stent in the Treatment of Diabetic Patients With De Novo Native Coronary Artery Lesions |
| Acronym | SCORPIUS |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | CYPHER sirolimus-eluting stent, uncoated Bx VELOCITY balloon-expandable stent |
| Enrollment | 200 |
| Start date | Nov 1, 2002 |
| Primary completion | May 1, 2005 |
| Completion | Nov 1, 2009 |
| First posted | Jul 3, 2007 |
| Last update posted | Dec 3, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: